Clinical trial
Sapropterin Expanded Access Program
NCT00484991 · BioMarin Pharmaceutical, Industry · Approved for marketing
Key facts
| NCT number | NCT00484991 |
|---|---|
| Title | Sapropterin Expanded Access Program |
| Official title | Sapropterin Expanded Access Program |
| Lead sponsor | BioMarin Pharmaceutical, Industry |
| Status | Approved for marketing |
| Study type | Expanded Access |
| Conditions | Phenylketonuria |
| Intervention type | Drug |
| Interventions | Sapropterin dihydrochloride |
| First posted | Jun 12, 2007 |
| Last update posted | Apr 15, 2008 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: